EMT and Dissemination Precede Pancreatic Tumor Formation
Overview
Authors
Affiliations
Metastasis is the leading cause of cancer-associated death but has been difficult to study because it involves a series of rare, stochastic events. To capture these events, we developed a sensitive method to tag and track pancreatic epithelial cells in a mouse model of pancreatic cancer. Tagged cells invaded and entered the bloodstream unexpectedly early, before frank malignancy could be detected by rigorous histologic analysis; this behavior was widely associated with epithelial-to-mesenchymal transition (EMT). Circulating pancreatic cells maintained a mesenchymal phenotype, exhibited stem cell properties, and seeded the liver. EMT and invasiveness were most abundant at inflammatory foci, and induction of pancreatitis increased the number of circulating pancreatic cells. Conversely, treatment with the immunosuppressive agent dexamethasone abolished dissemination. These results provide insight into the earliest events of cellular invasion in situ and suggest that inflammation enhances cancer progression in part by facilitating EMT and entry into the circulation.
Targeting the NPY/NPY1R signaling axis in mutant p53-dependent pancreatic cancer impairs metastasis.
Chambers C, Watakul S, Schofield P, Howell A, Zhu J, Tran A Sci Adv. 2025; 11(11):eadq4416.
PMID: 40073121 PMC: 11900870. DOI: 10.1126/sciadv.adq4416.
Chito-oligosaccharide impairs the proliferation, invasion and migration of pancreatic cancer cells.
Liu H, Ding S, Lyu W, Lu S, Liu X Discov Oncol. 2025; 16(1):298.
PMID: 40069446 PMC: 11896950. DOI: 10.1007/s12672-025-02015-2.
Neutrophil Extracellular Traps Promote Pancreatic Cancer Progression via the STING Pathway.
Qu M, Zhu C, Sun C, Zhu S, Zhang H, Miao C Gastroenterol Res Pract. 2025; 2025:4950214.
PMID: 40046958 PMC: 11882324. DOI: 10.1155/grp/4950214.
Evolutionary fingerprints of epithelial-to-mesenchymal transition.
Perelli L, Zhang L, Mangiameli S, Giannese F, Mahadevan K, Peng F Nature. 2025; .
PMID: 40044861 DOI: 10.1038/s41586-025-08671-2.
Verona F, Di Bella S, Schirano R, Manfredi C, Angeloro F, Bozzari G Front Immunol. 2025; 16:1529847.
PMID: 39981232 PMC: 11839637. DOI: 10.3389/fimmu.2025.1529847.